Misplaced Pages

Citiolone: Difference between revisions

Article snapshot taken from Wikipedia with creative commons attribution-sharealike license. Give it a read and then ask your questions in the chat. We can research this topic together.
Browse history interactively
Page 1
Page 2
← Previous editContent deleted Content addedVisualWikitext
Revision as of 14:12, 12 August 2011 editCheMoBot (talk | contribs)Bots141,565 edits Updating {{drugbox}} (no changed fields - added verified revid - updated 'ChEMBL_Ref', 'ChEBI_Ref', 'ChEBI_Ref') per Chem/Drugbox validation (report [[Misplaced Pages talk:WikiProject_Pharmacology|erro← Previous edit Latest revision as of 05:28, 30 October 2023 edit undoBoghog (talk | contribs)Autopatrolled, Extended confirmed users, IP block exemptions, New page reviewers, Pending changes reviewers, Rollbackers, Template editors137,584 edits consistent citation formatting 
(14 intermediate revisions by 13 users not shown)
Line 1: Line 1:
{{Short description|Chemical compound}}
{{drugbox
{{Drugbox
| Verifiedfields = changed
| Watchedfields = changed
| verifiedrevid = 444443115
| IUPAC_name = (''RS'')-''N''-(2-Oxothiolan-3-yl)acetamide
| image = Citiolone.png

<!--Clinical data-->
| tradename =
| pregnancy_AU = <!-- A / B1 / B2 / B3 / C / D / X -->
| pregnancy_US = <!-- A / B / C / D / X -->
| pregnancy_category =
| legal_AU = <!-- S2, S3, S4, S5, S6, S7, S8, S9 or Unscheduled-->
| legal_CA = <!-- Schedule I, II, III, IV, V, VI, VII, VIII -->
| legal_UK = <!-- GSL, P, POM, CD, or Class A, B, C -->
| legal_US = <!-- OTC / Rx-only / Schedule I, II, III, IV, V -->
| legal_status =
| routes_of_administration =

<!--Pharmacokinetic data-->
| bioavailability =
| protein_bound =
| metabolism =
| elimination_half-life =
| excretion =

<!--Identifiers-->
| CAS_number_Ref = {{cascite|correct|??}}
| CAS_number = 1195-16-0
| ATC_prefix = A05
| ATC_suffix = BA04
| PubChem = 14520
| DrugBank_Ref = {{drugbankcite|correct|drugbank}}
| DrugBank =
| ChEMBL_Ref = {{ebicite|changed|EBI}}
| ChEMBL = 2104457
| ChemSpiderID_Ref = {{chemspidercite|correct|chemspider}}
| ChemSpiderID = 13864
| UNII_Ref = {{fdacite|correct|FDA}} | UNII_Ref = {{fdacite|correct|FDA}}
| UNII = 70JKL15MUH | UNII = 70JKL15MUH
| verifiedrevid = 443501665
| IUPAC_name = (''RS'')-''N''-(2-Oxothiolan-3-yl)acetamide
| image = Citiolone.png
| CAS_number = 1195-16-0
| PubChem = 14520
| ChemSpiderID_Ref = {{chemspidercite|correct|chemspider}}
| ChemSpiderID = 13864
| SMILES = O=C1SCCC1NC(=O)C
| StdInChI_Ref = {{stdinchicite|correct|chemspider}}
| StdInChI=1S/C6H9NO2S/c1-4(8)7-5-2-3-10-6(5)9/h5H,2-3H2,1H3,(H,7,8)
| StdInChIKey_Ref = {{stdinchicite|correct|chemspider}}
| StdInChIKey = NRFJZTXWLKPZAV-UHFFFAOYSA-N
| ATC_prefix = A05
| ATC_suffix = BA04
| PubChem = 14520
| DrugBank_Ref = {{drugbankcite|correct|drugbank}}
| DrugBank =
| KEGG_Ref = {{keggcite|correct|kegg}} | KEGG_Ref = {{keggcite|correct|kegg}}
| KEGG = D07105 | KEGG = D07105

| C=6|H=9|N=1|O=2|S=1
<!--Chemical data-->
| molecular_weight = 159.21 g/mol
| C=6 | H=9 | N=1 | O=2 | S=1
| bioavailability =
| StdInChI_Ref = {{stdinchicite|correct|chemspider}}
| protein_bound =
| StdInChI = 1S/C6H9NO2S/c1-4(8)7-5-2-3-10-6(5)9/h5H,2-3H2,1H3,(H,7,8)
| metabolism =
| StdInChIKey_Ref = {{stdinchicite|correct|chemspider}}
| elimination_half-life =
| StdInChIKey = NRFJZTXWLKPZAV-UHFFFAOYSA-N
| excretion =
| pregnancy_AU = <!-- A / B1 / B2 / B3 / C / D / X -->
| pregnancy_US = <!-- A / B / C / D / X -->
| pregnancy_category=
| legal_AU = <!-- S2, S3, S4, S5, S6, S7, S8, S9 or Unscheduled-->
| legal_CA = <!-- Schedule I, II, III, IV, V, VI, VII, VIII -->
| legal_UK = <!-- GSL, P, POM, CD, or Class A, B, C -->
| legal_US = <!-- OTC / Rx-only / Schedule I, II, III, IV, V -->
| legal_status =
| routes_of_administration =
}} }}


'''Citiolone''' is a drug used in liver therapy. It is a derivative of the ] ]. '''Citiolone''' is a drug used in ] therapy.

It is a derivative of the ] ].<ref>{{cite journal | vauthors = de Barrio M, Tornero P, Prieto A, Sainza T, Zubeldia JM, Herrero T | title = Recurrent fixed drug eruption caused by citiolone | journal = Journal of Investigational Allergology & Clinical Immunology | volume = 7 | issue = 3 | pages = 193–194 | year = 1997 | pmid = 9252880 }}</ref> Citilone has also been studied with regards to ] due to it being a ] free radical scavenger. The drug has been shown to protect ] cells subjected to temperature conditions of 8-25&nbsp;°C.<ref>{{cite journal | vauthors = Kruuv J, Glofcheski DJ | title = Further evidence for two modes of hypothermia damage | journal = Cryobiology | volume = 30 | issue = 3 | pages = 313–321 | date = June 1993 | pmid = 8370318 | doi = 10.1006/cryo.1993.1030 }}</ref>

== References ==
{{reflist}}


{{Bile and liver therapy}} {{Bile and liver therapy}}